Abstract
Clinical trials are research studies performed in humans to evaluate the efficacy and safety of an intervention. They are the primary method by which researchers discover if a new treatment (drug, diet, medical device) is safe and effective in humans. DNA vaccines are considered, by definition, advanced therapy medicinal products (ATMPs). ATMPs are medicines for human use that are based on genes, tissues, or cells. They offer groundbreaking new opportunities for the treatment of disease and injury. Clinical trials using ATMPs are subject to specific regulatory requirements. This chapter will describe the most important steps when planning a clinical trial with DNA vaccines, such as regulatory and submission requirements, designing of a successful clinical trial protocol, stakeholders’ responsibilities, and feasibility assessment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dresser R (2009) First-in-human trial participants: not a vulnerable population, but vulnerable nonetheless. J Law Med Ethics 37:38–50
Johan PE, Karlberg JPE, Speers MA (2010) Reviewing clinical trials: a guide for the Ethics Committee, Clinical Trials Centre, The University of Hong Kong Hong Kong SAR, PR China
Umscheid CA, Margolis DJ, Grossman CE (2011) Key concepts of clinical trials: a narrative review. Postgrad Med 123:194–204
Cingi C, Muluk NB (2016) Quick guide to good clinical practice how to meet international quality standard in clinical research. Springer, New York
Directive 2001/20/EC of The European Parliament and of The Council on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
European Commission Enterprise and Industry Directorate-General Consumer goods Pharmaceuticals Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials to be included in The rules governing medicinal products in the European Union, vol 10: Clinical Trials Notice to Applicants Chapter V Additional Information (2011)
The rules governing medicinal products in the European Union, vol 10—Guidance documents applying to clinical trials guidance on investigational medicinal products (Imps) and ‘Non Investigational Medicinal Products’ (NIMPS) (2011)
Regulation (EC) No. 1394/2007 Regulation of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use
Al-Jundi A, Sakka S (2016) Protocol writing in clinical research. J Clin Diagn Res 10:ZE10–ZE13
International Conference on Harmonization (1996) E6(R1): good clinical practice
Chung KC, Song JW, WRIST study group (2010) A guide on organizing a multicenter clinical trial: the WRIST study group. Plast Reconstr Surg 126:515–523
Kracov DA, Dwyer LM (2006) Regulatory requirements for clinical studies of medical devices and diagnostics. In: Becker KM, Whyte JJ (eds) Clinical evaluation of medical devices. Principles and case studies, 2nd edn. Humana Press, Totowa
Rajadhyaksha V (2010) Conducting feasibilities in clinical trials: an investment to ensure a good study. Perspect Clin Res 1:106–109
Johnson O (2015) An evidence-based approach to conducting clinical trial feasibility assessments. Clin Invest 5:491–499
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ramalhinho, A.C., Castelo-Branco, M. (2021). Preparation of an Academic Clinical Trial. In: Sousa, Â. (eds) DNA Vaccines. Methods in Molecular Biology, vol 2197. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0872-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0872-2_18
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0871-5
Online ISBN: 978-1-0716-0872-2
eBook Packages: Springer Protocols